These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 9839740)

  • 21. Acceptability of medical abortion with methotrexate and misoprostol.
    Creinin MD; Park M
    Contraception; 1995 Jul; 52(1):41-4. PubMed ID: 8521713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Provision of harm-reduction services to limit unsafe abortion in Tanzania.
    Kahabuka C; Pembe A; Meglioli A
    Int J Gynaecol Obstet; 2017 Feb; 136(2):210-214. PubMed ID: 28099731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A risk reduction strategy to prevent maternal deaths associated with unsafe abortion.
    Briozzo L; Vidiella G; Rodríguez F; Gorgoroso M; Faúndes A; Pons JE
    Int J Gynaecol Obstet; 2006 Nov; 95(2):221-6. PubMed ID: 17010348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Misoprostol and attempted self-induction of abortion.
    Jones MM; Fraser K
    J R Soc Med; 1998 Apr; 91(4):204-5. PubMed ID: 9659308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe morbidities associated with induced abortions among misoprostol users and non-users in a tertiary public hospital in Ghana.
    Damalie FJ; Dassah ET; Morhe ES; Nakua EK; Tagbor HK; Opare-Addo HS
    BMC Womens Health; 2014 Jul; 14():90. PubMed ID: 25074294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute intravaginal misoprostol toxicity with fetal demise.
    Austin J; Ford MD; Rouse A; Hanna E
    J Emerg Med; 1997; 15(1):61-4. PubMed ID: 9017489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Women use illicit drug to induce abortion.
    Indian Med Trib; 1993 Sep; 1(6):11. PubMed ID: 12179168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Illegal abortions in Addis Ababa, Ethiopia.
    Tadesse E; Yoseph S; Gossa A; Muletta E; Pogharian D; Ketsella K; Hawaz Z
    East Afr Med J; 2001 Jan; 78(1):25-9. PubMed ID: 11320760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H; Hinshaw K; Templeton A
    Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early pregnancy termination with mifepristone and misoprostol in the United States.
    Spitz IM; Bardin CW; Benton L; Robbins A
    N Engl J Med; 1998 Apr; 338(18):1241-7. PubMed ID: 9562577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Illegal induced abortion: a study of 74 cases in Ile-Ife, Nigeria.
    Okonofua FE; Onwudiegwu U; Odunsi OA
    Trop Doct; 1992 Apr; 22(2):75-8. PubMed ID: 1604719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induced abortion in Kenya: its determinants and associated factors.
    Lema VM; Rogo KO; Kamau RK
    East Afr Med J; 1996 Mar; 73(3):164-8. PubMed ID: 8698013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Misoprostol: the experience of women in Fortaleza, Brazil.
    Coêlho HL; Teixeira AC; Cruz Mde F; Gonzaga SL; Arrais PS; Luchini L; La Vecchia C; Tognoni G
    Contraception; 1994 Feb; 49(2):101-10. PubMed ID: 8143449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Embryonic abnormalities at medical termination of pregnancy with mifepristone and misoprostol during first trimester: observational study.
    Blanch G; Quenby S; Ballantyne ES; Gosden CM; Neilson JP; Holland K
    BMJ; 1998 Jun; 316(7146):1712-3. PubMed ID: 9614021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Misoprostol and declining abortion-related morbidity in Santo Domingo, Dominican Republic: a temporal association.
    Miller S; Lehman T; Campbell M; Hemmerling A; Anderson SB; Rodriguez H; Gonzalez WV; Cordero M; Calderon V
    BJOG; 2005 Sep; 112(9):1291-6. PubMed ID: 16101610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health care providers' perceptions of using misoprostol in the treatment of incomplete abortion in Malawi.
    Wagenheim CA; Savosnick H; Chakhame BM; Darj E; Kafulafula UK; Maluwa A; Odland JØ; Odland ML
    BMC Health Serv Res; 2022 Dec; 22(1):1471. PubMed ID: 36461125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safe abortion information hotlines: An effective strategy for increasing women's access to safe abortions in Latin America.
    Drovetta RI
    Reprod Health Matters; 2015 May; 23(45):47-57. PubMed ID: 26278832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health benefits of legal abortion: an analysis.
    Tyrer LB
    Plan Parent Rev; 1985; 5(2):24-7. PubMed ID: 12340404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of self-induced abortion with misoprostol, admitted to a provincial hospital in Papua New Guinea: A prospective observational study.
    Bolnga JW; Lufele E; Teno M; Agua V; Ao P; Dl Mola G; Pomat W; Laman M
    Aust N Z J Obstet Gynaecol; 2021 Dec; 61(6):955-960. PubMed ID: 34350583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Brazilian experience with Cytotec.
    Barbosa RM; Arilha M
    Stud Fam Plann; 1993; 24(4):236-40. PubMed ID: 8212093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.